|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 495/04 | |
| A61K 31/407 |
| (11) | Patento numeris | 3271365 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16714004.5 |
| Europos patento paraiškos padavimo data | 2016-03-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2016/051465 |
| Data | 2016-03-15 |
| (87) | Numeris | WO 2016/151432 |
| Data | 2016-09-29 |
| (30) | Numeris | Data | Šalis |
| 201562136223 P | 2015-03-20 | US | |
| 201562138505 P | 2015-03-26 | US |
| (72) |
MADERNA, Andreas, US
SUBRAMANYAM, Chakrapani, US
TUMEY, Lawrence N., US
CHEN, Zecheng, US
CASAVANT, Jeffrey M., US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE |
| BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE |